OmniAb (OABI) Operating Margin (2022 - 2026)
OmniAb's (OABI) quarterly Operating Margin came in at 54.27% in Q1 2026, up 39937.0% year-on-year from N/an in Q1 2025, and up 71.17% on a QoQ basis from 188.23% in Q4 2025.
OmniAb (OABI) Operating Margin (2022 - 2026) Analysis & Trends
OmniAb (OABI) has 5 years of Operating Margin data on file, last reported at 54.27% in Q1 2026.
- On a quarterly basis, Operating Margin rose 39937.0% year-over-year to 54.27% in Q1 2026; TTM through Mar 2026 was 200.26%, a 6444.0% increase from a year earlier, with the FY2025 full-year figure at 369.49%, down 8719.0% from the prior year.
- Operating Margin for Q1 2026 stood at 54.27%, up from 188.23% in the prior quarter.
- Over the last five years, Operating Margin for OABI reached as high as 25.6% in Q4 2022 and fell as low as 810.18% in Q3 2025.
- Historically, Operating Margin has averaged 290.67% across 5 years, with a median of 215.76% in 2022.
- Across the five-year window, Operating Margin sank 54338 bps in 2024 and soared 39937 bps in 2026, its largest moves.
- Year by year, Operating Margin stood at 25.6% in 2022, then slumped by 1818 bps to 439.78% in 2023, then soared by 67 bps to 146.98% in 2024, then declined by 28 bps to 188.23% in 2025, then jumped by 71 bps to 54.27% in 2026.
- Per Business Quant data, the three most recent Operating Margin figures were 54.27% in Q1 2026, 188.23% in Q4 2025, and 810.18% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 16.51% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 38.10% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 17.83% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 31.68% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | OmniAb | 261.62 Mn | 212.55 Mn | 14.41 Mn | -54.27% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -54.27% |
| Dec 31, 2025 | -188.23% |
| Sep 30, 2025 | -810.18% |
| Jun 30, 2025 | -416.19% |
| Mar 31, 2025 | -453.64% |
| Dec 31, 2024 | -146.98% |
| Sep 30, 2024 | -473.73% |
| Jun 30, 2024 | -214.14% |
| Mar 31, 2024 | -593.34% |
| Dec 31, 2023 | -439.78% |
| Sep 30, 2023 | -370.91% |
| Jun 30, 2023 | -279.95% |
| Mar 31, 2023 | -49.96% |
| Dec 31, 2022 | 25.60% |
| Sep 30, 2022 | -215.76% |
| Jun 30, 2022 | -174.55% |
| Mar 31, 2022 | -85.45% |